Comments
Loading...
Lantern Pharma (LTRN) Forecast
NewsEarningsLantern Pharma (LTRN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestLantern Pharma (NASDAQ:LTRN) Stock Quotes, Forecast and News Summary
Lantern Pharma Stock (NASDAQ: LTRN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Lantern Pharma (LTRN) stock?
You can purchase shares of Lantern Pharma (NASDAQ:LTRN) through any online brokerage.
Who are Lantern Pharma (LTRN) competitors?
Other companies in Lantern Pharma’s space includes: OncoCyte (NASDAQ:OCX), Intensity Therapeutics (NASDAQ:INTS), Palatin Techs (AMEX:PTN), Precision BioSciences (NASDAQ:DTIL) and vTv Therapeutics (NASDAQ:VTVT).
What is the forecast, or price target, for Lantern Pharma (LTRN) stock?
Lantern Pharma has a consensus price target of $11.00.
What is the current price for Lantern Pharma (LTRN)?
The stock price for Lantern Pharma (NASDAQ: LTRN) is $3.3122 last updated January 2, 2025 at 12:44 PM EST.
Does Lantern Pharma (LTRN) pay a dividend?
There are no upcoming dividends for Lantern Pharma.
When is Lantern Pharma (NASDAQ:LTRN) reporting earnings?
Lantern Pharma’s Q4 earnings are confirmed for Monday, March 17, 2025.
Is Lantern Pharma (LTRN) going to split?
There is no upcoming split for Lantern Pharma.
What sector and industry does Lantern Pharma (LTRN) operate in?
Lantern Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.